Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$70,369,463
in 12 filings, $45.5M under 10b5-1 plans

Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-28 QVT Financial LP 10% owner Sale −446,394 $11.55 $5.2M 5,023,787
2023-09-28 Gold Daniel Allen Director Sale −8,957 $11.55 $103K 100,804
2023-09-28 Gold Daniel Allen Director Sale −2,285,783 $11.55 $26.4M 25,724,561
2023-09-28 Gold Daniel Allen Director Sale −3,059,368 $11.55 $35.3M 34,430,591
2023-09-28 Gold Daniel Allen Director Sale −3,094,899 $11.55 $35.7M 34,830,463
2023-09-28 Gold Daniel Allen Director Sale −1,104,599 $11.55 $12.8M 12,431,330
2023-09-28 Gold Daniel Allen Director Sale −446,394 $11.55 $5.2M 5,023,787
2023-09-28 Gline Matthew CEO Other disposition −10,243 $12.67 $130K 1,041,240
2023-09-28 Ramaswamy Vivek 10% owner Other disposition −61,947 $12.67 $785K 54,788,110
2023-09-28 Kumar Rakhi Chief Accounting Officer Other disposition −92 $12.67 $1K 196,624
2023-09-27 Venker Eric President & COO Option exercise +500,000 $3.85 $1.9M 1,095,397
2023-09-27 Venker Eric President & COO Sale −500,000 $13.02 $6.5M 595,397
2023-09-27 Venker Eric President & COO Option exercise · Stock Option (Right to Buy) −500,000 13,823,184
2023-09-27 Sukhatme Mayukh Pres&Chief Investment Officer Option exercise +27,790 3,217,750
2023-09-27 Sukhatme Mayukh Pres&Chief Investment Officer Option exercise · Capped Value Appreciation Rights −53,033 $6.40 $339K 2,015,263
2023-09-27 Sukhatme Mayukh Pres&Chief Investment Officer Option exercise · Capped Value Appreciation Rights −28,411 $11.50 $327K 1,335,300
2023-09-27 Gline Matthew CEO Option exercise +17,762 1,051,483
2023-09-27 Gline Matthew CEO Option exercise · Capped Value Appreciation Rights −28,411 $6.40 $182K 1,164,836
2023-09-27 Gline Matthew CEO Option exercise · Capped Value Appreciation Rights −47,351 $11.50 $545K 2,225,501
2023-09-27 Ramaswamy Vivek 10% owner Option exercise +119,534 54,850,057

Page 37 of 38 · 748 trades